Therapeutic choices, and the nurse practitioner's role, in type 2 diabetes when metformin alone is no longer enough

Journal of the American Academy of Nurse Practitioners
Kathryn Tierney

Abstract

This article provides an overview of the currently available treatments for type 2 diabetes (T2D), outlining the most up to date information to assist nurse practitioners (NPs) to make informed prescribing decisions for T2D therapy once patients are no longer able to maintain blood glucose control using lifestyle modification and/or metformin therapy. Published guidelines for the management of T2D, review articles, primary manuscripts, and FDA prescribing information documents. In the past, options for the treatment of T2D were limited. However, there is now an ever increasing number of available therapeutic choices for T2D, that, as well as glycemic control, offer significant additional benefits, particularly in terms of reducing hypoglycemic risk and weight gain. Consequently, these newer agents provide both patients and NPs with a much greater choice for ongoing therapy. The differing benefits and risk profiles shown by the currently available antidiabetic treatments provide NPs with a unique opportunity to tailor treatment plans more closely to the requirements of each patient. This approach can ensure that the right drug reaches the right patient, which should in turn promote greater treatment compliance and improved outco...Continue Reading

References

Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Oct 17, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Jul 2, 2003·Diabetes Care·Philip RaskinUNKNOWN Repaglinide vs. Nateglinide Metformin Combination Study Group
May 27, 2004·Diabetes Care·Julio RosenstockUNKNOWN Repaglinide Versus Nateglinide Comparison Study Group
Jul 22, 2005·The Cochrane Database of Systematic Reviews·A SaenzD Moher
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Mar 1, 2007·Diabetes Care·David M NathanUNKNOWN American Diabetes Association
Jul 19, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Helena W RodbardUNKNOWN AACE Diabetes Mellitus Clinical Practice Guidelines Task Force
Jan 8, 2009·Journal of Clinical Pharmacy and Therapeutics·G DerosaA F G Cicero
Oct 28, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Helena W RodbardStanley S Schwartz
Nov 11, 2009·Journal of the American Academy of Nurse Practitioners·Allison Wick, Kelley Newlin
Mar 25, 2010·Diabetes Care·John B BuseUNKNOWN Liraglutide Effect Action in Diabetes-6 Study Group
Jan 14, 2011·Diabetes Care·UNKNOWN American Diabetes Association
Feb 22, 2011·Gastroenterology·Michael ElashoffPeter C Butler
Apr 16, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehuda HandelsmanUNKNOWN AACE Task Force for Developing Diabetes Comprehensive Care Plan
Jun 28, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jaime A DavidsonDavid Scott
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Carolyn Robertson
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Geralyn R Spollett
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Davida F Kruger
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Tom Bartol

❮ Previous
Next ❯

Citations

May 18, 2012·Journal of the American Academy of Nurse Practitioners·Tom Bartol
May 18, 2012·Journal of the American Academy of Nurse Practitioners·Carolyn Robertson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.